Literature DB >> 11781242

Tyrosine phosphorylation of B-cell adaptor for phosphoinositide 3-kinase is required for Akt activation in response to CD19 engagement.

Kazunori Inabe1, Tomohiro Kurosaki.   

Abstract

CD19 is a coreceptor that amplifies signaling initiated by antigen cross-linking of the B-cell antigen receptor (BCR). CD19 can also signal independently of BCR coligation. This study shows that B-cell adaptor for phosphoinositide 3-kinase (BCAP), previously characterized as a substrate of the tyrosine kinases upon BCR engagement, is phosphorylated by cross-linking of CD19. Tyrosine phosphorylation of BCAP, mediated by Lyn, provides binding site(s) for phosphoinositide 3-kinase (PI3K), thereby participating in Akt activation. Thus, these results provide evidence that BCAP serves as an adaptor molecule for CD19 to activate the PI3K pathway in B cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11781242     DOI: 10.1182/blood.v99.2.584

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

1.  Monophosphorylation of CD79a and CD79b ITAM motifs initiates a SHIP-1 phosphatase-mediated inhibitory signaling cascade required for B cell anergy.

Authors:  Shannon K O'Neill; Andrew Getahun; Stephen B Gauld; Kevin T Merrell; Idan Tamir; Mia J Smith; Joseph M Dal Porto; Quan-Zhen Li; John C Cambier
Journal:  Immunity       Date:  2011-11-09       Impact factor: 31.745

2.  B-cell adaptor for PI3K (BCAP) negatively regulates Toll-like receptor signaling through activation of PI3K.

Authors:  Minjian Ni; Alexander W MacFarlane; Michelle Toft; Clifford A Lowell; Kerry S Campbell; Jessica A Hamerman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-20       Impact factor: 11.205

3.  MHC class II structural requirements for the association with Igalpha/beta, and signaling of calcium mobilization and cell death.

Authors:  Lei Jin; John C Stolpa; Ryan M Young; Aimee E Pugh-Bernard; Yosef Refaeli; John C Cambier
Journal:  Immunol Lett       Date:  2007-12-26       Impact factor: 3.685

Review 4.  Toll-like receptors, signaling adapters and regulation of the pro-inflammatory response by PI3K.

Authors:  Ty Dale Troutman; J Fernando Bazan; Chandrashekhar Pasare
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

Review 5.  NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms.

Authors:  Li Yu; Ling Li; L Jeffrey Medeiros; Ken H Young
Journal:  Blood Rev       Date:  2016-10-13       Impact factor: 8.250

Review 6.  Signaling mechanisms regulating B-lymphocyte activation and tolerance.

Authors:  Elias Hobeika; Peter J Nielsen; David Medgyesi
Journal:  J Mol Med (Berl)       Date:  2015-01-29       Impact factor: 4.599

7.  Role for B-cell adapter for PI3K (BCAP) as a signaling adapter linking Toll-like receptors (TLRs) to serine/threonine kinases PI3K/Akt.

Authors:  Ty Dale Troutman; Wei Hu; Stephanie Fulenchek; Tetsuo Yamazaki; Tomohiro Kurosaki; J Fernando Bazan; Chandrashekhar Pasare
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-20       Impact factor: 11.205

8.  Characterization of Lamprey IL-17 Family Members and Their Receptors.

Authors:  Qifeng Han; Sabyasachi Das; Masayuki Hirano; Stephen J Holland; Nathanael McCurley; Peng Guo; Charles S Rosenberg; Thomas Boehm; Max D Cooper
Journal:  J Immunol       Date:  2015-10-21       Impact factor: 5.422

Review 9.  Status of PI3K/Akt/mTOR pathway inhibitors in lymphoma.

Authors:  Jason R Westin
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2014-02-07

Review 10.  Inhibitors of B-cell receptor signaling for patients with B-cell malignancies.

Authors:  Michael Y Choi; Thomas J Kipps
Journal:  Cancer J       Date:  2012 Sep-Oct       Impact factor: 3.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.